Researcher.Life Logo

Translational Andrology and Urology : Impact Factor & More

eISSN: 2223-4691pISSN: 2223-4683

Key Metrics

CiteScore
2.5
Impact Factor
< 5
SJR
Q2Urology
SNIP
1.04
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Translational Andrology and Urology

Translational Andrology and Urology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher AME PUBLISHING COMPANY
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2012
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Translational Andrology and Urology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Translational Andrology and Urology

Urinary PENK DNA methylation for bladder cancer diagnosis: methodological rigor, interpretive boundaries, and the evidence required for clinical translation
  • 1 Apr 2026
  • Translational Andrology and Urology
Aberrant methylation of mitochondrial genes as a link between oxidative phosphorylation dysregulation and the pathogenesis of hypospadias: a multiomics and clinical sample study
  • 1 Apr 2026
  • Translational Andrology and Urology
Circulating tumor DNA as a prognostic biomarker in adjuvant nivolumab therapy for high-risk muscle-invasive urothelial carcinoma: insights from CheckMate 274 and beyond
  • 1 Apr 2026
  • Translational Andrology and Urology
Preliminary feasibility and safety of domestic probe-based confocal laser endomicroscopy in the diagnosis of bladder lesions: a prospective single-arm cohort study
  • 1 Apr 2026
  • Translational Andrology and Urology
Comparative performance of five nephrolithometry scoring systems and a novel nomogram for predicting stone-free rate following pediatric percutaneous nephrolithotomy
  • 1 Apr 2026
  • Translational Andrology and Urology
Efficacy and safety of a novel 18 mmol/L sodium citrate hemofiltration solution in continuous renal replacement therapy for critically ill patients: a retrospective cohort study
  • 1 Apr 2026
  • Translational Andrology and Urology
Urinary PENK DNA methylation for bladder cancer diagnosis: methodological rigor, interpretive boundaries, and the evidence required for clinical translation
  • 1 Apr 2026
  • Translational Andrology and Urology
Aberrant methylation of mitochondrial genes as a link between oxidative phosphorylation dysregulation and the pathogenesis of hypospadias: a multiomics and clinical sample study
  • 1 Apr 2026
  • Translational Andrology and Urology
Circulating tumor DNA as a prognostic biomarker in adjuvant nivolumab therapy for high-risk muscle-invasive urothelial carcinoma: insights from CheckMate 274 and beyond
  • 1 Apr 2026
  • Translational Andrology and Urology
Preliminary feasibility and safety of domestic probe-based confocal laser endomicroscopy in the diagnosis of bladder lesions: a prospective single-arm cohort study
  • 1 Apr 2026
  • Translational Andrology and Urology
Comparative performance of five nephrolithometry scoring systems and a novel nomogram for predicting stone-free rate following pediatric percutaneous nephrolithotomy
  • 1 Apr 2026
  • Translational Andrology and Urology
Efficacy and safety of a novel 18 mmol/L sodium citrate hemofiltration solution in continuous renal replacement therapy for critically ill patients: a retrospective cohort study
  • 1 Apr 2026
  • Translational Andrology and Urology

FAQs on Translational Andrology and Urology